Crossmark

Drug-Induced Photosensitivity—An Update: Culprit Drugs, Prevention and Management

Crossref DOI link: https://doi.org/10.1007/s40264-019-00806-5

Published Online: 2019-03-19

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Blakely, Kim M.

Drucker, Aaron M.

Rosen, Cheryl F. https://orcid.org/0000-0002-5807-0445
License Information

Text and Data Mining valid from 2019-03-19
More Information

Article History

First Online: 19 March 2019

Compliance with Ethical Standards

:

: Kim M. Blakely, Aaron M. Drucker and Cheryl F. Rosen have no conflicts of interest that are directly related to the content of this study. Outside of this work, Aaron M. Drucker has served as an investigator and has received research funding from Sanofi and Regeneron and has been a consultant for Sanofi, RTI Health Solutions, Eczema Society of Canada and Canadian Agency for Drugs and Technology in Health. He has received honoraria from Prime Inc, Spire Learning, CME Outfitters and Eczema Society of Canada. His institution has received educational grants from Sanofi. Outside of this work, Cheryl F. Rosen has served as a consultant for AbbVie Corporation, Janssen Inc. and Novartis Pharmaceuticals. She also receives research support from AbbVie and Janssen. Her institution has received educational grants from Bausch, Celgene, AbbVie and Janssen.

: No sources of funding were used to assist in the preparation of this study.